Evaluation of Adding Desmopressin to Alpha Blockers in Treatment of Nocturia in Cases of Benign Prostatic Hyperplasia: A Prospective Randomized Clinical Study | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 31, Volume 85, Issue 2, October 2021, Page 3654-3658 PDF (511.62 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejhm.2021.201983 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Khaled Mohammed Abdelwahab; AbdEllatif Mohammed AbdEllatif; Ibrahim Ali Ibrahim Jaedah  ; Maged Mohammed Ali
| ||||
| Abstract | ||||
| Background: Nocturia is one of the most bothersome symptom of lower urinary tract symptoms in males with Benign Prostatic Hyperplasia (BPH). Alpha blockers has good effect in relieving bladder outlet obstruction. Objective: The aim of the present study was to provide best available medical treatment for nocturia in patients of BPH. Patients and methods: This prospective study was carried out on 44 male patients complaining of lower urinary tract symptoms (LUTS) of BPH with nocturia, were enrolled in this prospective randomized study for 12 weeks. They were divided randomly into 2 groups, each group included 22 patients. Group A: the patient received oral desmopressin added to tamsulosin once daily. Group B, the patient received oral tamsulosin daily. Results: The mean serum Na of patients at group A was 142.35. No significant difference regarding in-between groups before treatment but at after 12 week of treatment; group A was (mean of Na=137.68±2.033) significantly lower than group B and significantly decreased from before to after treatment. There was no significant difference between groups in both nocturnal void and nocturnal volume before treatment and after treatment as group A was significantly lower and both groups significantly changed and improved from before to after treatment. No significant difference was found at before treatment regarding total International Prostate Symptom Score (IPSS) but group A was significantly lower regarding total IPSS after treatment and both groups significantly decreased after treatment (6.36±2.59 in group A and 10.55±4.13 in group B). Conclusion: Addition of desmopressin to α-blockers is an active therapy for men with BPH and suffering nocturia and is preferred than α-blockers therapy alone. | ||||
| Keywords | ||||
| Alpha Blockers; BPH; Desmopressin; Nocturia | ||||
|
Statistics Article View: 182 PDF Download: 284 |
||||
